ESR1 and breast cancer: Triple-negative breast cancer (TNBC), which lack the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is an aggressive subtype of breast cancer with higher risk of early relapse and poor prognosis when compared with other subtypes22.